Target intelligence / Profile preview

Kidney yin deficiency syndrome (KYDS) (KYDS)

Target
KYDS
Molecular classification
Other
01

Overview

Kidney yin deficiency syndrome (KYDS) is a fundamental pathological pattern in Traditional Chinese Medicine (TCM) characterized by the depletion of "Yin" essence, leading to a loss of moistening and cooling functions within the body (WHO International Standard Terminologies, 2007). It is clinically identified by symptoms such as night sweats, malar flush, dizziness, and a rapid, thin pulse (PMID: 31211314). Modern biomedical research suggests that KYDS is not a single molecular entity but a systemic state of dysregulation involving the neuroendocrine-immune (NEI) network and the hypothalamic-pituitary-adrenal (HPA) axis (PMID: 28655536). Therapeutic interventions, such as the herbal formula Liuwei Dihuang Wan, target this syndrome to restore homeostatic balance by modulating cortisol levels and inflammatory cytokines (PMID: 25635150). Consequently, KYDS serves as a diagnostic framework for treating various chronic conditions, including diabetes, hypertension, and menopausal symptoms, where it correlates with specific metabolic and hormonal imbalances (PMID: 30104553). Addressing this syndrome involves a multi-target approach that influences oxidative stress and metabolic regulation rather than a single receptor interaction.

Other names
Shen-Yin-XuKidney Yin DeficiencyRenal Yin DeficiencyDeficiency of Kidney Yin
02

Mechanism of action

Herbal interventions for this syndrome typically function by nourishing the Yin essence, clearing deficiency-derived heat, and modulating the hypothalamic-pituitary-adrenal (HPA) axis to restore systemic homeostasis (PMID: 28655536).

03

Biological functions

Immune responseOther
04

Disease associations

InflammationCardiovascular diseaseOther
05

Safety considerations

Risk of misdiagnosis with Kidney Yang deficiencyPotential heavy metal contamination in herbal preparationsHerb-drug interactions with Western pharmaceuticals (PMID: 25635150)
06

Interacting drugs

Liuwei Dihuang Wan

4 more in the full profile.

07

Biomarkers

17-hydroxycorticosteroid (17-OHCS)Urinary cortisolcAMP/cGMP ratioMetabolomic signatures (PMID: 31211314)

Beyond the preview

Go deeper on Kidney yin deficiency syndrome (KYDS) (KYDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kidney yin deficiency syndrome (KYDS) (KYDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call